Results for parapsilosis translation from Danish to English

candida parapsilosis: s ≤0,06 mg/l, r >0,06 mg/l
candida parapsilosis: s ≤0.06 mg/l, r >0.06 mg/l

non- albicans species ¶: alle c. tropicalis c. parapsilosis c. glabrata c. krusei
98 140 51 44 17 7

de arter, der oftest forårsager infektioner hos mennesker, omfatter c. albicans, c. parapsilosis,
the species most frequently involved in causing human infections include c. albicans, c. parapsilosis,

ligeledes kan c. parapsilosis-isolater, som er intermediært følsomme for anidulafungin og micafungin, anses for at være intermediært følsomme for caspofungin.
similarly, c. parapsilosis isolates intermediate to anidulafungin and micafungin can be regarded intermediate to caspofungin.

2 i kliniske studier var responset på voriconazol 21% lavere hos patienter med infektion med c. glabrata sammenlignet med c. albicans, c. parapsilosis og
2 in clinical studies, response to voriconazole in patients with c. glabrata infections was 21% lower compared to c. albicans, c. parapsilosis and c. tropicalis.

1c. parapsilosis har en iboende forandring i målgenet, som sandsynligvis er mekanismen bag de højere mic-værdier sammenlignet med andre candida-arter.
1c. parapsilosis harbours an intrinsic alteration in the target gene, which is the likely mechanism for the higher mics than with other candida species.

anidulafungin udviser in vitro-aktivitet over for c. albicans, c. glabrata, c. parapsilosis, c. krusei og c. tropicalis.
anidulafungin exhibited in-vitro activity against c. albicans, c. glabrata, c. parapsilosis, c. krusei and c. tropicalis.

2 i kliniske forsøg var responset på voriconazol 21% lavere hos patienter med infektion med c. glabrata sammenlignet med c. albicans, c. parapsilosis og c. tropicalis.
2 in clinical studies, response to voriconazole in patients with c glabrata infections was 21% lower compared to c. albicans, c. parapsilosis and c. tropicalis.

in vitro- aktivitet anidulafungin udviser in vitro- aktivitet over for c. albicans, c. glabrata, c. parapsilosis, og c. tropicalis.
activity in vitro anidulafungin exhibited in-vitro activity against c. albicans, c. glabrata, c. parapsilosis, and c. tropicalis.

klinisk effekt (med delvist eller fuldstændigt respons, se neden for under klinisk erfaring) er vist over for aspergillus spp. herunder a. flavus, a. fumigatus, a. terreus, a. niger, a. nidulans, candida spp., herunder c. albicans c. glabrata, c. krusei, c. parapsilosis, c. tropicalis samt et begrænset antal af c. dubliniensis, c. inconspicua og c. guilliermondii, scedosporium spp., herunder s. apiospermum, s. prolificans og fusarium spp.
clinical efficacy (with partial or complete response, see below under clinical experience) has been demonstrated for aspergillus spp. including a. flavus, a. fumigatus, a. terreus, a. niger, a. nidulans, candida spp., including c. albicans, c. glabrata, c. krusei, c. parapsilosis and c. tropicalis and limited numbers of c. dubliniensis, c. inconspicua, and c. guilliermondii, scedosporium spp., including s. apiospermum, s. prolificans and fusarium spp.